Neurotensin receptor 1 gene activation by the Tcf/β-catenin pathway is an early event in human colonic adenomas

Carcinogenesis

Volumn 27, Issue 4, 2006, Pages 708-716

  Souazé, Frédérique ^a   Viardot Foucault, Véronique ^a   Roullet, Nicolas ^a   Toy Miou Leong, Mireille ^a   Gompel, Anne ^a   Bruyneel, Erik ^b   Comperat, Eva ^a   Faux, Maree C ^c   Mareel, Marc ^b   Rostène, William ^a   Fléjou, Jean François ^a   Gespach, Christian ^a   Forgez, Patricia ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; CALCIUM; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL JUNCTION; CELL NUCLEUS; CELL STRAIN COS7; CELL STRAIN HEK293; COLON ADENOMA; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; CYTOSOL; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; PROMOTER REGIONS (GENETICS); RECEPTORS, NEUROTENSIN; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; UP-REGULATION; WNT PROTEINS;

EID: 33645279248     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi269     Document Type: Article

References (47)

1. Heasley,L.E. (2001) Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene, 20, 1563-1569.
2. Vogt,S., Grosse,R., Schultz,G. and Offermanns,S. (2003) Receptor-dependent RhoA activation in G12/G13-deficient cells: Genetic evidence for an involvement of Gq/G1l. J. Biol. Chem., 278, 28743-28749.
3. Jaffe,A.B. and Hall,A. (2002) Rho GTPases in transformation and metastasis. Adv. Cancer Res., 84, 57-80.
4. Lozano,E., Betson,M. and Braga,V.M. (2003) Tumor progression: Small GTPases and loss of cell-cell adhesion. Bioessays, 25, 452-463.
5. Nguyen,Q.D., Faivre,S., Bruyneel,E., Rivat,C., Seto,M., Endo,T., Mareel,M., Emami,S. and Gespach,C. (2002) RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasion. FASEB J., 16, 565-576.
6. Najimi,M., Maloteaux,J.M. and Hermans,E. (2002) Cytoskeleton-related trafficking of the EAAC1 glutamate transporter after activation of the G(q/11)-coupled neurotensin receptor NTS1. FEBS Lett., 523, 224-228.
7. Zhao,D., Kuhnt-Moore,S., Zeng,H., Wu,J.S., Moyer,M.P. and Pothoulakis,C. (2003) Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. Am. J. Physiol. Cell Physiol., 284, C1397-C1404.
8. Leyton,J., Garcia-Marin,L., Jensen,R.T. and Moody,T.W. (2002) Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells. Eur. J. Pharmacol., 442, 179-186.
9. Reinecke,M. (1985) Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone. Prog. Histochem. Cytochem., 16, 1-172.
10. Draviam,E.J., Upp,J.R., Jr., Greeley,G.H., Jr., Townsend,C.M., Jr. and Thompson,J.C. (1990) Effect of oral fat on plasma levels of neurotensin and neurotensin fragments in humans. Characterization by high-pressure liquid chromatography. Dig. Dis. Sci., 35, 200-204.
11. Giovannucci,E. (2002) Modifiable risk factors for colon cancer. Gastroenterol. Clin. North Am., 31, 925-943.
12. Thomas,R.P., Hellmich,M.R., Townsend,C.M., Jr. and Evers,B.M. (2003) Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues. Endocr. Rev., 24, 571-599.
13. Maoret,J.J., Anini,Y., Rouyer-Fessard,C., Gully,D. and Laburthe,M. (1999) Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int. J. Cancer, 80, 448-454.
14. Moody,T.W., Chiles,J., Casibang,M., Moody,E., Chan,D. and Davis,T.P. (2001) SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells. Peptides, 22, 109-115.
15. Maoret,J.J., Pospai,D., Rouyer-Fessard,C., Couvineau,A., Laboisse,C., Voisin,T. and Laburthe,M. (1994) Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: Binding studies and RT-PCR experiments. Biochem. Biophys. Res. Commun., 203, 465-471.
16. Kinzler,K.W. and Vogelstein,B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
17. Morin,P.J., Sparks,A.B., Korinek,V., Barker,N., Clevers,H., Vogelstein,B. and Kinzler,K.W. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 275, 1787-1790.
18. van Es,J.H., Barker,N. and Clevers,H. (2003) You Wnt some, you lose some: Oncogenes in the Wnt signaling pathway. Curr. Opin. Genet. Dev., 13, 28-33.
19. Faux,M.C., Ross,J.L., Meeker,C., Johns,T., Ji,H., Simpson,R.J., Layton,M.J. and Burgess,A.W. (2004) Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J. Cell. Sci., 117, 427-439.
20. Gompel,A., Malet,C., Spritzer,P., Lalardrie,J.P., Kuttenn,F. and Mauvais-Jarvis,P. (1986) Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J. Clin. Endocrinol. Metab., 63, 1174-1180.
21. Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Korinek,V., Barker,N., Morin,P.J., van Wichen,D., de Weger,R., Kinzler,K.W., Vogelstein,B. and Clevers,H. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science, 275, 1784-1787.
23. Therrien,M. and Drouin,J. (1993) Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol. Cell. Biol., 13, 2342-2353.
24. Souaze,F., Rostene,W. and Forgez,P. (1997) Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms. J. Biol. Chem., 272, 10087-10094.
25. Su,L.K., Vogelstein,B. and Kinzler,K.W. (1993) Association of the APC tumor suppressor protein with catenins. Science, 262, 1734-1737.
26. Boudin,H., Grauz-Guyon,A., Faure,M.P., Forgez,P., Lhiaubet,A.M., Dennis,M., Beaudet,A., Rostene,W. and Pelaprat,D. (1995) Immunological recognition of different forms of the neurotensin receptor in transfected cells and rat brain. Biochem. J., 305, 277-283.
27. Kurnellas,M.P., Nicot,A., Shull,G.E. and Elkabes,S. (2005) Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: A potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury. FASEB J., 19, 298-300.
28. Bracke,M.E, Boterberg,T., Bruyneel E.A. and Mareel M.M. (2000) Collagen invasion assay. In: Brooks,S.A. and Schumacher,U. (eds), Methods in Molecular Medicine, Vol. 58: Metastasis Research Protocols and Vol. 2: Cell Behavior in Vitro and in Vivo. Humana Press, Totowa, NJ, pp. 81-89.
29. Jourdan,F., Sebbagh,N., Comperat,E., Mourra,N., Flahault,A., Olschwang,S., Duval,A., Hamelin,R. and Flejou,J.F. (2003) Tissue microarray technology: Validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch., 443, 115-121.
30. Cagatay,T. and Ozturk,M. (2002) P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells. Oncogene, 21, 7971-7980.
31. Le,F., Groshan,K., Zeng,X.P. and Richelson,E. (1997) Characterization of the genomic structure, promoter region, and a tetranucleotide repeat polymorphism of the human neurotensin receptor gene. J. Biol. Chem., 272, 1315-1322.
32. Brabletz,T., Jung,A., Hermann,K., Gunther,K., Hohenberger,W. and Kirchner,T. (1998) Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol. Res. Pract., 194, 701-704.
33. Miyaki,M., Iijima,T., Kimura,J., Yasuno,M., Mori,T., Hayashi,Y., Koike,M., Shitara,N., Iwama,T. and Kuroki,T. (1999) Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res., 59, 4506-4509.
34. Fodde,R., Smits,R. and Clevers,H. (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer, 1, 55-67.
35. van de Wetering,M., Sancho,E., Verweij,C. et al. (2002) The beta-catenin/ TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111, 241-250.
36. Guha,S., Rey,O. and Rozengurt,E. (2002) Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res., 62, 1632-1640.
37. Kisfalvi,K., Guha,S. and Rozengurt,E. (2005) Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells. J. Cell. Physiol., 202, 880-890.
38. Somai,S., Gompel,A., Rostene,W. and Forgez,P. (2002) Neurotensin counteracts apoptosis in breast cancer cells. Biochem. Biophys. Res. Commun., 295, 482-488.
39. Gullo,L., Pezzilli,R., Tomassetti,P. and de Giorgio,R.P. (1998) Plasma cholecystokinin and neurotensin after an ordinary meal in humans. A prolonged time study. Gastroenterol. Clin. Biol., 22, 25-28.
40. Banker,N.A., Hellmich,M.R., Kim,H.J., Townsend,C.M., Jr. and Evers,B.M. (1997) Src-mediated activation of the human neurotensin/neuromedin N promoter. Surgery, 122, 180-185.
41. Evers,B.M., Zhou,Z., Celano,P. and Li,J. (1995) The neurotensin gene is a downstream target for Ras activation. J. Clin. Invest., 95, 2822-2830.
42. Giardiello,F.M., Hamilton,S.R., Krush,A.J., Piantadosi,S., Hylind,L.M., Celano,P., Booker,S.V., Robinson,C.R. and Offerhaus,G.J. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316.
43. Steinbach,G., Lynch,P.M., Phillips,R.K. et al. (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342, 1946-1952.
44. Castagliuolo,I., Wang,C.C., Valenick,L., Pasha,A., Nikulasson,S., Carraway,R.E. and Pothoulakis,C. (1999) Neurotensin is a proinflammatory neuropeptide in colonic inflammation. J. Clin. Invest., 103, 843-849.
45. Zhao,D., Zhan,Y., Zeng,H., Koon,H.W., Moyer,M.P. and Pothoulakis,C. (2005) Neurotensin stimulates interleukin-8 expression through modulation of I{kappa}B{alpha} phosphorylation and p65 transcriptional activity: Involvement of protein kinase C[alpha]. Mol. Pharmacol., 67, 2025-2031.
46. Zhao,D., Zhan,Y., Koon,H.W., Zeng,H., Keates,S., Moyer,M.P. and Pothoulakis,C. (2004) Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J. Biol. Chem., 279, 43547-43554.
47. Brun,P., Mastrotto,C., Beggiao,E., Stefani,A., Barzon,L., Sturniolo,G.C., Palu,G. and Castagliuolo,I. (2005) Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 288, G621-G629.